6505--Nitroglycerin Patches
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79727R0010
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
This presolicitation notice announces the forthcoming release of Request for Proposal (RFP) 36E79727R0010 by the VA National Acquisition Center (NAC Pharmaceuticals), a federal office under the Department of Veterans Affairs. The procurement seeks to establish an unrestricted contract for the supply of Nitroglycerin Patches, classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505. The contract will support the pharmaceutical needs of multiple federal healthcare entities, including the Department of Veterans Affairs (encompassing Consolidated Mail Order Pharmacies and State Veterans Homes), Department of Defense, Bureau of Prisons, Indian Health Service, and the Federal Health Care Center.
The primary objective of this procurement is to secure a reliable, uninterrupted source of Nitroglycerin Patches in four dosage strengths: 0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg. The estimated annual requirements are substantial, with projected usage as follows: 4,982 boxes of 0.1 mg patches, 10,044 boxes of 0.2 mg patches, 8,720 boxes of 0.4 mg patches, and 2,213 boxes of 0.6 mg patches. Each box must contain 30 patches, and both the outer packaging and individual patches are required to be barcoded for inventory and distribution purposes.
The contract will be awarded to a single responsible offeror capable of meeting all supply and labeling requirements, ensuring consistent availability throughout the contract period. The base contract term is one year, with four additional one-year option periods, all pre-priced. Distribution of the contracted items will occur through the VA’s and DoD’s Pharmaceutical Prime Vendor Programs, ensuring streamlined delivery to end users.
Key requirements for offerors include:
- The drug must be supplied under the exact name as it appears on the product label, with a unique National Drug Code (NDC) specific to the offeror.
- The successful contractor’s label and NDC must be the only ones present on the product; relabeling over another manufacturer’s label is strictly prohibited.
- VA labels must be able to securely adhere over the contractor’s label if necessary.
- Unit of use packaging is not required, but all patches must be boxed and barcoded as specified.
The solicitation will be issued electronically in accordance with FAR Part 12 (Commercial Items) on or about December 1, 2026, with a tentative closing date of December 15, 2026. All solicitation documents, amendments, and related materials will be available exclusively via SAM.gov; no paper copies will be provided, and telephone requests will not be accepted. Interested offerors are encouraged to monitor the SAM.gov listing for updates and amendments.
This opportunity is open to all responsible sources, with no set-aside restrictions indicated. Contractors must ensure compliance with all labeling, packaging, and distribution requirements as outlined. The primary point of contact for this procurement is Jacob Werling, Contract Specialist, who can be reached at [email protected] for any questions or clarifications.
This procurement represents a significant opportunity for pharmaceutical manufacturers with the capacity to deliver high-volume, federally compliant nitroglycerin patches and to support the critical healthcare needs of multiple federal agencies over a multi-year contract lifecycle.